 VALENCIA, Calif., Oct. 27, 2020 GLOBE NEWSWIRE -- AVITA Therapeutics, Inc. NASDAQ: RCEL, ASX:AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today it plans to release its first quarter 2021 financial results after the market closes on Wednesday, November 11, 2020. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific time 4:30 p.m. Eastern time to discuss its financial results and recent highlights. 